Scarica l'app Stockscreener
7.30
1.39%
0.10
Journey Medical Corp Borsa (DERM) Ultime notizie
Journey Medical Corporation Stock Analysis and ForecastFree Technical Analysis Support - Jammu Links News
Will Journey Medical Corporation stock split in the near futureHigh Accuracy Alerts - Newser
YDAPP(ydapp) Project ReviewBreakout Setup Scanner - Newser
What makes Journey Medical Corporation stock price move sharplyWealth Building Stock Portfolio - Newser
What makes KINS stock price move sharplyFree Access to Community - Newser
What makes Ellington Financial Inc. stock price move sharplyWeekly Big Movers - Newser
Why Journey Medical Corporation stock attracts strong analyst attentionMomentum Buy Alert - Newser
What makes Star Fashion Culture Holdings Limited stock price move sharplyLow Risk Scalping Alerts - Newser
What makes Autonomix Medical Inc. stock price move sharplyTop Rated Trade Entries - Newser
Why LPL Financial Holdings Inc. stock attracts strong analyst attentionFree Financial Group - Newser
What makes ATMCU stock price move sharplyFree Real-Time Trading Opportunities - Newser
When DCOMP stock expected to show significant growthIs CCEP stock a good long term investment optionSteady Profit Stock Forecasts - Newser
How Journey Medical Corporation stock performs during market volatilityWealth Building Stock Portfolio - Newser
How AmpliTech Group Inc. stock performs during market volatilityFree Real-Time Stock Data - Newser
Why Outset Medical Inc. stock attracts strong analyst attentionProfit Focused Trade Alerts - Newser
How AirJoule Technologies Corporation stock performs during market volatilityTop Performing Stocks - Newser
Why Orthofix Medical Inc. stock attracts strong analyst attentionSmart Money Trade Setups - Newser
Journey Medical Expands Pharmacy Coverage for Emrosi - TipRanks
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi?? - MarketScreener
Journey Medical’s rosacea treatment reaches 65% commercial coverage - Investing.com
Journey Medical announces expanded payer coverage for Emrosi - TipRanks
Journey Medical's Emrosi Coverage Jumps to 65% of U.S. Commercial Lives - MarketScreener
Journey Medical Corporation Reports Increase in Payer Coverage for Emrosi™ to 65% of Commercial Lives, Supporting Growing Prescription Demand - Quiver Quantitative
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ - Stock Titan
From Need to Reimbursed Technology: Lessons from an 11-Year Journey - Stanford Medicine
Tailforce Unleashes Ozzy: The World’s First AI Executive Assistant Doggo for Smarter Email, Scheduling, and Customer Support - Quantisnow
Journey Medical (NASDAQ:DERM) Rating Lowered to “Hold” at Wall Street Zen - Defense World
Cambridge Investment Research Advisors Inc. Boosts Holdings in Journey Medical Corporation (NASDAQ:DERM) - Defense World
Journey Medical Corporation(NasdaqCM: DERM) added to Russell 2000 Growth Index - MarketScreener
DERM SEC FilingsJourney Medical Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Journey Medical Corp Holds 2025 Annual Stockholders Meeting - TipRanks
Is Journey Medical Corp. overvalued or undervalued? - MarketsMojo
Journey Medical Joins Russell 2000 and 3000 Indices - TipRanks
Fortress Biotech shareholders approve board proposals at annual meeting - Investing.com
Journey Medical Corporation (NASDAQ:DERM) Short Interest Update - MarketBeat
Journey Medical (NASDAQ:DERM) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Wall Street Zen Downgrades Journey Medical (NASDAQ:DERM) to Hold - Defense World
Journey Medical Co. (NASDAQ:DERM) Receives Average Rating of "Buy" from Analysts - MarketBeat
Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand - Yahoo Finance
Journey Medical (DERM) Highlights Emrosi on National TV | DERM S - GuruFocus
Journey Medical announces Emrosi featured on “The Balancing Act” - TipRanks
Birchtech Strengthens Water Treatment Commercialization Team with Strategic Leadership Appointments - The Manila Times
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - Yahoo Finance
44,568 Shares in Journey Medical Co. (NASDAQ:DERM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Takes Position in Mingteng International Co. Inc. (NASDAQ:MTEN) - Defense World
Journey Medical stock soars to 52-week high of $8.25 By Investing.com - Investing.com South Africa
Journey Medical stock soars to 52-week high of $8.25 - Investing.com
Tang Capital Management LLC Buys Shares of 1,725,569 Journey Medical Co. (NASDAQ:DERM) - MarketBeat
Contrasting Amarantus BioScience (OTCMKTS:AMBS) and Journey Medical (NASDAQ:DERM) - Defense World
Q2 EPS Estimates for Journey Medical Reduced by Roth Capital - MarketBeat
Quipt Home Medical Corp: Navigating the Financial Waters - timothysykes.com
Journey Medical Q2 EPS Forecast Decreased by Roth Capital - Defense World
20,455 Shares in Journey Medical Co. (NASDAQ:DERM) Purchased by Dimensional Fund Advisors LP - Defense World
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript - Insider Monkey
Journey Medical price target lowered to $10 from $10.50 at Alliance Global - TipRanks
Trading Resumes for Journey Medical (DERM) Corp | DERM Stock New - GuruFocus
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Journey Medical (DERM) Surpasses Q1 Revenue Expectations with Su - GuruFocus
1.09%
3.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):